Login / Signup

Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymerase.

Robert P HayesMee Ra HeoMark MasonJohn ReidChristine BurleinKira A ArmacostDavid M TellersIzzat RaheemAnthony W ShawEdward MurrayPhilip M McKennaPravien AbeywickremaSujata SharmaStephen M SoissonDaniel Klein
Published in: Nature communications (2021)
All herpesviruses encode a conserved DNA polymerase that is required for viral genome replication and serves as an important therapeutic target. Currently available herpesvirus therapies include nucleoside and non-nucleoside inhibitors (NNI) that target the DNA-bound state of herpesvirus polymerase and block replication. Here we report the ternary complex crystal structure of Herpes Simplex Virus 1 DNA polymerase bound to DNA and a 4-oxo-dihydroquinoline NNI, PNU-183792 (PNU), at 3.5 Å resolution. PNU bound at the polymerase active site, displacing the template strand and inducing a conformational shift of the fingers domain into an open state. These results demonstrate that PNU inhibits replication by blocking association of dNTP and stalling the enzyme in a catalytically incompetent conformation, ultimately acting as a nucleotide competing inhibitor (NCI). Sequence conservation of the NCI binding pocket further explains broad-spectrum activity while a direct interaction between PNU and residue V823 rationalizes why mutations at this position result in loss of inhibition.
Keyphrases
  • single molecule
  • circulating tumor
  • cell free
  • structural basis
  • herpes simplex virus
  • nucleic acid
  • transcription factor
  • sars cov
  • gene expression
  • circulating tumor cells
  • genome wide
  • reduced graphene oxide